Substance based medical devices are classified according to Rule 21 of MDR 2017/745 based on their intended use, route of administration and level of absorption or local dispersion in the human body. A structured evaluation supported by toxicological and regulatory expertise is essential to determine the correct classification and ensure compliance.


